Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665600 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
A Phase 3 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 3
- Development phase
- 257
- Enrollment target
NCT00665600: Completed Phase 3 study, sponsored by Sumitomo Pharma America.
NCT00665600 is a Phase 3 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 257 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00665600, a Phase 3 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 257 participants
- Enrollment target
Study Summary
To investigate the efficacy and safety of repeated dosing of Levalbuterol over 6 weeks of treatment in COPD.
Interventions
- DRUG Placebo
- DRUG Albuterol Sulfate
- DRUG Levalbuterol HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2002-02 |
| Est. Completion | 2003-03 |
| Phase | Phase 3 |
What the finished NCT00665600 record still lists
NCT00665600 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00665600 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00665600 about?
NCT00665600 is a clinical study titled "Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)". To investigate the efficacy and safety of repeated dosing of Levalbuterol over 6 weeks of treatment in COPD.
What is the current status of trial NCT00665600?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 257 participants. The study started on 2002-02. Estimated completion is 2003-03.
What interventions are being tested in trial NCT00665600?
The interventions under investigation include: Placebo (DRUG), Albuterol Sulfate (DRUG), Levalbuterol HCl (DRUG).
Who is sponsoring clinical trial NCT00665600?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00665600's enrollment target sits among peer trials
257 1238th of 2000 higher than 761 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia